These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22936118)

  • 1. Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats.
    Lee JH; Lee A; Oh JH; Lee YJ
    Biopharm Drug Dispos; 2012 Nov; 33(8):474-86. PubMed ID: 22936118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
    Choi YH; Suh JH; Lee JH; Cho IH; Lee MG
    J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cysteine on the pharmacokinetics of paclitaxel in rats.
    Lee YK; Han SY; Chin YW; Choi YH
    Arch Pharm Res; 2012 Mar; 35(3):509-16. PubMed ID: 22477198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity.
    van Waterschoot RA; Lagas JS; Wagenaar E; van der Kruijssen CM; van Herwaarden AE; Song JY; Rooswinkel RW; van Tellingen O; Rosing H; Beijnen JH; Schinkel AH
    Cancer Res; 2009 Dec; 69(23):8996-9002. PubMed ID: 19920203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5'-diphosphoglucuronic acid level.
    Kang HE; Sohn SI; Baek SR; Lee JW; Lee MG
    Metabolism; 2010 Oct; 59(10):1472-80. PubMed ID: 20170928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of paclitaxel, docetaxel and their combinations on subcutaneous lymphomas in inbred Sprague-Dawley/Cub rats.
    Otová B; Václavíková R; Danielová V; Holubová J; Ehrlichová M; Horský S; Soucek P; Simek P; Gut I
    Eur J Pharm Sci; 2006 Dec; 29(5):442-50. PubMed ID: 17000091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin.
    Yan YD; Kim DH; Sung JH; Yong CS; Choi HG
    Int J Pharm; 2010 Oct; 399(1-2):116-20. PubMed ID: 20727390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous-to-oral switch in anticancer chemotherapy: a focus on docetaxel and paclitaxel.
    Koolen SL; Beijnen JH; Schellens JH
    Clin Pharmacol Ther; 2010 Jan; 87(1):126-9. PubMed ID: 19924122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous and oral administration of mirodenafil to streptozotocin-induced diabetes mellitus rats.
    Lee YS; Choi YH; Kim TK; Ryu KH; Lee BY; Lee MG
    Xenobiotica; 2010 Feb; 40(2):129-37. PubMed ID: 19929308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ipriflavone and its two metabolites, M1 and M5, after the intravenous and oral administration of ipriflavone to rat model of diabetes mellitus induced by streptozotocin.
    Lee DY; Chung HJ; Choi YH; Lee U; Kim SH; Lee I; Lee MG
    Eur J Pharm Sci; 2009 Dec; 38(5):465-71. PubMed ID: 19761842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
    Bae SK; Kim JY; Yang SH; Kim JW; Kim T; Lee MG
    Life Sci; 2006 Apr; 78(20):2287-94. PubMed ID: 16288785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats.
    Zhang W; Tan TM; Lim LY
    Drug Metab Dispos; 2007 Jan; 35(1):110-5. PubMed ID: 17050652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of morin on the pharmacokinetics of docetaxel in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors.
    Yang SH; Lee JH; Lee DY; Lee MG; Lyuk KC; Kim SH
    Arch Pharm Res; 2011 Oct; 34(10):1729-34. PubMed ID: 22076773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation.
    Kim YC; Lee AK; Lee JH; Lee I; Lee DC; Kim SH; Kim SG; Lee MG
    Eur J Pharm Sci; 2005 Sep; 26(1):114-23. PubMed ID: 15985363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.
    Bae SK; Yang SH; Lee SJ; Kwon JW; Kim WB; Lee DC; Lee MG
    Eur J Pharm Sci; 2005 Jun; 25(2-3):337-45. PubMed ID: 15911231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes.
    de Graan AJ; Sparreboom A; de Bruijn P; de Jonge E; van der Holt B; Wiemer EA; Verweij J; Mathijssen RH; van Schaik RH
    Br J Clin Pharmacol; 2015 Sep; 80(3):560-8. PubMed ID: 26119961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of experimental hyperlipidaemia on the pharmacokinetics of docetaxel in rats.
    Lee JH; Oh JH; Lee YJ
    Xenobiotica; 2011 Sep; 41(9):797-804. PubMed ID: 21561320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1.
    Lee DY; Lee MG; Shin HS; Lee I
    J Pharm Pharm Sci; 2007; 10(4):420-33. PubMed ID: 18261364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.